🇺🇸 Lactulose oral solution in United States
78 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 78
Most-reported reactions
- Drug Ineffective — 26 reports (33.33%)
- Blood Glucose Increased — 8 reports (10.26%)
- Vomiting — 8 reports (10.26%)
- Abdominal Pain Upper — 7 reports (8.97%)
- Diarrhoea — 7 reports (8.97%)
- Nausea — 6 reports (7.69%)
- Abdominal Distension — 4 reports (5.13%)
- Constipation — 4 reports (5.13%)
- Flatulence — 4 reports (5.13%)
- Rectal Haemorrhage — 4 reports (5.13%)
Other Gastroenterology approved in United States
Frequently asked questions
Is Lactulose oral solution approved in United States?
Lactulose oral solution does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Lactulose oral solution in United States?
Peking Union Medical College Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.